Account Health & Retention Intelligence

Health Model R²: 0.78
Last sync: 8 min ago
GRR (Trailing 12M)
91.2%
Revenue-at-Risk
$3.8M
Avg Health Score
68/100
Accounts <50 Health
47
Intervention Success
72%
Median Usage Slope
+1.2%

Account Health vs. Revenue Exposure

Health Tier Distribution — 12-Month Trend

Health Component Profile — At-Risk Accounts

Health Component Benchmarking

Churn Prediction vs. Actuals

Account Risk Register

Account Segment ARR Health Days to Renewal Usage Trend Support (L90D) Last Engage NPS Billing Issues Intervention CSM
GlobalBank Corp Enterprise $420K 24 38 12 4d 18 2 In Progress Rachael Torres
Meridian Logistics Enterprise $290K 34 112 8 18d 42 1 Planned Marcus Chen
Apex Pharma Mid-Market $245K 41 145 5 22d 51 0 None Sofia Patel
Sterling Retail Mid-Market $180K 28 67 9 31d 28 3 Planned Rachael Torres
Quantum Finance Enterprise $385K 48 203 6 14d 58 0 None Marcus Chen
Vertex Manufacturing Mid-Market $195K 52 89 4 9d 64 0 Completed Sofia Patel
Cascade Biotech Mid-Market $210K 36 156 7 26d 39 1 None Marcus Chen
Nexus Health Enterprise $340K 58 178 3 7d 71 0 None Rachael Torres

GRR Bridge — Trailing 12M

Churn Reason Analysis

Intervention Impact by Playbook

Top At-Risk Accounts — Usage Trends

GlobalBank Corp ($420K)
24
Quantum Finance ($385K)
48
Nexus Health ($340K)
58
Meridian Logistics ($290K)
34
Apex Pharma ($245K)
41
Cascade Biotech ($210K)
36

Renewal Calendar — ARR by Health Tier

Cohort Retention Curves — Quarterly